Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells-Reference-Cited by-同舟云学术

Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells

Published:2013-10-11 Issue:11 Volume:104 Page:1492-1498
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Okuhira Keiichiro¹,Demizu Yosuke²,Hattori Takayuki¹,Ohoka Nobumichi¹,Shibata Norihito¹,Nishimaki-Mogami Tomoko¹,Okuda Haruhiro²,Kurihara Masaaki²,Naito Mikihiko¹

Affiliation:

1. Division of Biochemistry and Molecular Biology; National Institute of Health Sciences; Tokyo Japan

2. Division of Organic Chemistry; National Institute of Health Sciences; Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12272/fullpdf

Reference25 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Immunohistochemistry of estrogen and progesterone receptors reconsidered;Morales;Am J Clin Path,2005

3. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting;Hall;Mol Interv,2005

4. Molecular basis of agonism and antagonism in the oestrogen receptor;Brzozowski;Nature,1997

5. Tamoxifen therapy for breast cancer and endometrial cancer risk;Bernstein;J Natl Cancer Inst,1999

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications;European Journal of Medicinal Chemistry;2024-09

2. Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment;International Journal of Biological Macromolecules;2024-08

3. EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue;Chemical Biology & Drug Design;2024-04

4. Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation;ACS Chemical Biology;2024-02-02

5. The application of PROTAC in HDAC;European Journal of Medicinal Chemistry;2023-11